Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Cancer,
Location: Houston TX, Louisville KY, Toronto, Orange CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06219941

Phase 2, Recruiting

Phase II Clinical Trial of Interleukin-2 in AD

for
Alzheimer Disease
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 50 - 70+

Code: NCT06096090

Phase 2, Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

for
B-cell Malignancies
Location: Houston TX, Charlotte NC, Winston-Salem NC,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06542250

Phase 1, Phase 2, Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Houston TX, Memphis TN, Nashville TN, Tampa FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06324357

Phase 1, Phase 2, Recruiting

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

for
Biliary Tract Cancer
Location: Houston TX, Dallas TX, Fort Worth TX, Kansas City MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06467357

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

for
Solid Tumors
Location: Houston TX, Nashville TN, St Louis MO, Denver CO,
Sponsor: Jacobio Pharmaceuticals Co., Ltd.

Sex: All

Age: 18+

Code: NCT06386146

Phase 1, Phase 2, Recruiting

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

for
Ischemic Stroke, Intracerebral Hemorrhage,
Location: Houston TX, San Antonio TX, Jackson MS, Memphis TN,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04916210

Recruiting

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

for
Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer,
Location: Houston TX, Aurora CO, Columbus OH, Detroit MI, London,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05797168

Phase 1, Phase 2, Recruiting

Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

for
Hiv
Location: Houston TX, New Orleans LA, Birmingham AL, St Louis MO,
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT06263426

Recruiting

Study of AZD0754 in Participants With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Houston TX, St Louis MO, Atlanta GA, Tampa FL,
Sponsor: AstraZeneca

Sex: Male

Age: 18 - 70+

Code: NCT06267729

Phase 1, Phase 2, Recruiting

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

for
Proteinuric Kidney Disease
Location: Houston TX, Shenandoah TX, San Antonio TX, Dallas TX,
Sponsor: Maze Therapeutics

Sex: All

Age: 18 - 68

Code: NCT06830629

Phase 2, Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

for
Asthma
Location: Houston TX, San Antonio TX, Dallas TX, Oklahoma City OK,
Sponsor: AstraZeneca

Sex: All

Age: 5 - 11

Code: NCT06023589

Phase 3, Recruiting

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

for
Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma,
Location: Houston TX, Miami FL, Philadelphia PA, Duarte CA,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT06137144

Phase 1, Phase 2, Recruiting

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

for
Hepatocellular Carcinoma
Location: Houston TX, St Louis MO, Los Angeles CA, Hackensack NJ
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06795022

Phase 1, Phase 2, Recruiting

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: Houston TX, St Louis MO, Albuquerque NM, Charlotte NC,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05123482

Phase 1, Phase 2, Recruiting

NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers

for
Advanced Small Intestine Cancer, Appendiceal Cancers
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07060014

Phase 1, Recruiting

Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

for
Alzheimer Dementia (AD)
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 50 - 70+

Code: NCT07651319

Phase 1, Phase 2, Recruiting

CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material

for
Aortic Valve Stenosis, Aortic Stenosis, Aortic Valve Disease
Location: San Antonio TX, New Orleans LA, Clearwater FL,
Sponsor: EmStop Inc

Sex: All

Age: 22+

Code: NCT07276711

Recruiting

Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

for
Solid Tumours
Location: Houston TX, Fairfax VA, New York NY, Providence RI
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07446855

Phase 1, Phase 2, Recruiting

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

for
Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia,
Location: Houston TX, Decatur IL, Durham NC
Sponsor: AstraZeneca

Sex: All

Age: 16+

Code: NCT07155226

Phase 1, Phase 2, Recruiting
Article preview image

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City